Goserelin: effective alternative in early breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1374, 2003-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Goserelin: A Review of its Use in the Treatment of Early Breast Cancer in Premenopausal and Perimenopausal Women

By Cheer Susan M. Plosker Greg L. Simpson Dene Wagstaff Antona J.

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2639-2655

Adis International

Access to resources Recommend Favorite

Short-course therapy effective in early breast cancer

Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Gemcitabine/epirubicin/docetaxel effective in early breast cancer

Inpharma, Vol. 1, Iss. 1471, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Anastrozole: In Early Breast Cancer

By Wellington K. Faulds D.M.

Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. : 2485-2492

Adis International

Access to resources Recommend Favorite

The widespread use of adjuvant therapy, mainly anthracyclines, over the last 10 years is effective for recurrence in patients with early breast cancer

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite